Dave Greenwald

Jaguar Gene Therapy LLC is a clinical stage biotechnology company based in Lake Forest, IL. Jaguar Gene Therapy LLC is dedicated to accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases. The company has a proven team of experts who have experience in bringing novel gene therapy treatments to patients and their families. Jaguar is rapidly advancing an initial pipeline of three programs, including targeting severe neurodevelopmental disorders, type 1 galactosemia, and type 1 diabetes. The company partner with Advanced Medicine Partners for manufacturing their therapeutics. Key investors include Deerfield Management Company, Arch Venture Partners, and Eli Lilly and Company. The company was founded by Daniel Gallo, and Joseph Nolan has been the CEO since 2020.

Apertura Gene Therapy LLC is a next-generation gene therapy company that is advancing gene therapies developed on their high-throughput platforms. The company is based in New York, NY. The company is expanding on the promise of gene therapy by building on advances in vector biology and protein engineering. Through AAV capsid engineering, they aim to accelerate therapies to patients living with genetic diseases. The company was founded by Ben Deverman. Joseph W. la Barge has been the CEO of the company since 2022.